Package 0480-3274-56

{"route": ["ORAL"], "spl_id": "a573cf28-59db-4cb3-84db-af7b77200b66", "openfda": {"upc": ["0304803274560", "0304803273563"], "unii": ["F9G8XE24IB"], "rxcui": ["2675187", "2675193", "2675195", "2675197", "2675199", "2675201", "2675203", "2675205"], "spl_set_id": ["ed51e463-7a03-4858-bbd2-882ce4753d5a"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0480-3274-56)", "package_ndc": "0480-3274-56", "marketing_start_date": "20240213"}], "brand_name": "ALVAIZ", "product_id": "0480-3274_a573cf28-59db-4cb3-84db-af7b77200b66", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "0480-3274", "generic_name": "Eltrombopag", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ALVAIZ", "active_ingredients": [{"name": "ELTROMBOPAG CHOLINE", "strength": "18 mg/1"}], "application_number": "NDA216774", "marketing_category": "NDA", "marketing_start_date": "20240213", "listing_expiration_date": "20271231"}